Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2025 03:00 ET | Source: Aztiq Consulting ehf.

Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt

REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company, has completed a...
February 08, 2024 17:30 ET | Source: PMI

Remicade Biosimilars Market Size & Share to Exceed USD 34.4 Billion by 2034, at CAGR of 9.30% - By PMI

Covina, Feb. 08, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Remicade Biosimilars Market size was valued at about USD 15.3 Billion in 2024 and expected to grow at CAGR of...
January 22, 2018 05:04 ET | Source: World Finance

Alvogen CEO Robert Wessman speaks exclusively to World Finance about new opportunities in generic pharmaceuticals

LONDON, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Industry disruptor Robert Wessman, the CEO of rapidly growing generic pharmaceuticals company Alvogen, shares his thoughts on the latest market trends in...
January 04, 2018 06:16 ET | Source: World Finance

A man on a mission to transform generic pharmaceuticals: Alvogen CEO and founder, Robert Wessman, discusses the company’s growth

LONDON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- The pharmaceuticals industry is going through one of its most exciting periods yet. Generic pharmaceuticals have taken off, leading to much more innovation...